CURR vs TECH · rev $37.8M vs P/E 65, rev $1.22B
Currenc Group Inc. Ordinary Shares (CURR) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Currenc Group Inc. Ordinary Shares (CURR) is a software - application company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported CURR revenue for 2025-12-31 was $37.8M. Net income was -$18.4M. Revenue was down 18.6% from 2024-12-31 to 2025-12-31. CURR currently screens at market cap $352.6M.
Latest reported TECH revenue for 2026-06-30 was $1.22B. Net income was $181.9M. Revenue was down 0.4% from 2025-06-30 to 2026-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
CURR currently screens at market cap $352.6M. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the CURR and TECH stock pages for the full models.
Not investment advice.